Lim S, Toh T, Hor J, Lim J, Lit L, Ahmad-Annuar A
NPJ Parkinsons Dis. 2025; 11(1):34.
PMID: 39988587
PMC: 11847920.
DOI: 10.1038/s41531-025-00884-6.
Lim S, Klein C
J Parkinsons Dis. 2024; 14(3):467-482.
PMID: 38552119
PMC: 11091652.
DOI: 10.3233/JPD-230376.
Salemi M, Lanza G, Salluzzo M, Schillaci F, Di Blasi F, Cordella A
Biomedicines. 2023; 11(12).
PMID: 38137339
PMC: 10740523.
DOI: 10.3390/biomedicines11123118.
Zhang X, Kortholt A
Biomolecules. 2023; 13(4).
PMID: 37189360
PMC: 10135577.
DOI: 10.3390/biom13040612.
Ng A, Ng E, Tan Y, Prakash K, Au W, Tan L
Sci Rep. 2018; 8(1):5346.
PMID: 29593234
PMC: 5871891.
DOI: 10.1038/s41598-018-23711-w.
Splicing: is there an alternative contribution to Parkinson's disease?.
La Cognata V, DAgata V, Cavalcanti F, Cavallaro S
Neurogenetics. 2015; 16(4):245-63.
PMID: 25980689
PMC: 4573652.
DOI: 10.1007/s10048-015-0449-x.
Lrrk2 R1628P variant is a risk factor for essential tremor.
Chao Y, Ng E, Tan L, Prakash K, Au W, Zhao Y
Sci Rep. 2015; 5:9029.
PMID: 25761573
PMC: 4356963.
DOI: 10.1038/srep09029.
Genetic variants of α-synuclein are not associated with essential tremor.
Ross O, Conneely K, Wang T, Vilarino-Guell C, Soto-Ortolaza A, Rajput A
Mov Disord. 2011; 26(14):2552-6.
PMID: 22025277
PMC: 3677575.
DOI: 10.1002/mds.23909.
Lingo2 variants associated with essential tremor and Parkinson's disease.
Wu Y, Prakash K, Rong T, Li H, Xiao Q, Tan L
Hum Genet. 2011; 129(6):611-5.
PMID: 21287203
DOI: 10.1007/s00439-011-0955-3.
Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.
Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C
Hum Mutat. 2010; 31(7):763-80.
PMID: 20506312
PMC: 3056147.
DOI: 10.1002/humu.21277.
Parkinson's disease and low frequency alleles found together throughout LRRK2.
Paisan-Ruiz C, Washecka N, Nath P, Singleton A, Corder E
Ann Hum Genet. 2009; 73(Pt 4):391-403.
PMID: 19489756
PMC: 5217459.
DOI: 10.1111/j.1469-1809.2009.00524.x.
LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease.
Zabetian C, Yamamoto M, Lopez A, Ujike H, Mata I, Izumi Y
Mov Disord. 2009; 24(7):1034-41.
PMID: 19343804
PMC: 2827255.
DOI: 10.1002/mds.22514.
Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease.
Biskup S, West A
Biochim Biophys Acta. 2008; 1792(7):625-33.
PMID: 18973807
PMC: 2745057.
DOI: 10.1016/j.bbadis.2008.09.015.
The nonsynonymous Thr105Ile polymorphism of the histamine N-methyltransferase is associated to the risk of developing essential tremor.
Ledesma M, Garcia-Martin E, Alonso-Navarro H, Martinez C, Jimenez-Jimenez F, Benito-Leon J
Neuromolecular Med. 2008; 10(4):356-61.
PMID: 18543121
DOI: 10.1007/s12017-008-8040-3.
Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations.
Chen-Plotkin A, Yuan W, Anderson C, McCarty Wood E, Hurtig H, Clark C
Neurology. 2007; 70(7):521-7.
PMID: 17914064
PMC: 3619720.
DOI: 10.1212/01.WNL.0000280574.17166.26.
The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence.
Tan E, Zhao Y, Skipper L, Tan M, Di Fonzo A, Sun L
Hum Genet. 2006; 120(6):857-63.
PMID: 17019612
DOI: 10.1007/s00439-006-0268-0.
PARK8 LRRK2 parkinsonism.
Haugarvoll K, Wszolek Z
Curr Neurol Neurosci Rep. 2006; 6(4):287-94.
PMID: 16822348
DOI: 10.1007/s11910-006-0020-0.
Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson's disease cohort.
Williams-Gray C, Goris A, Foltynie T, Brown J, Maranian M, Walton A
J Neurol Neurosurg Psychiatry. 2006; 77(5):665-7.
PMID: 16614029
PMC: 2117467.
DOI: 10.1136/jnnp.2005.085019.